Ahmad Khurshid, Baig Mohammad Hassan, Mushtaq Gohar, Kamal Mohammad Amjad, Greig Nigel H, Choi Inho
Department of Medical Biotechnology, Yeungnam University, Gyeongsan. Korea.
Department of Medical Biotechnology, Yeungnam University, 280 Daehak-ro, Gyeongsan, Gyeongbuk 712-749. Korea.
Curr Alzheimer Res. 2017;14(11):1190-1197. doi: 10.2174/1567205014666170203141151.
Alzheimer's disease (AD) is the most common and well-studied neurodegenerative disease (ND). Biological pathways, pathophysiology and genetics of AD show commonalities with other NDs viz. Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), Prion disease and Dentatorubral-pallidoluysian atrophy (DRPLA). Many of the NDs, sharing the common features and molecular mechanisms suggest that pathology may be directly comparable and be implicated in disease prevention and development of highly effective therapies.
In this review, a brief description of pathophysiology, clinical symptoms and available treatment of various NDs have been explored with special emphasis on AD. Commonalities in these fatal NDs provide support for therapeutic advancements and enhance the understanding of disease manifestation.
The studies concentrating on the commonalities in biological pathways, cellular mechanisms and genetics may provide the scope to researchers to identify few novel common target(s) for disease prevention and development of effective common drugs for multi-neurodegenerative diseases.
阿尔茨海默病(AD)是最常见且研究最多的神经退行性疾病(ND)。AD的生物学途径、病理生理学和遗传学与其他神经退行性疾病有共同之处,即帕金森病(PD)、肌萎缩侧索硬化症(ALS)、亨廷顿舞蹈病(HD)、朊病毒病和齿状核红核苍白球路易体萎缩症(DRPLA)。许多神经退行性疾病具有共同特征和分子机制,这表明其病理可能具有直接可比性,并与疾病预防和高效治疗方法的开发有关。
在本综述中,探讨了各种神经退行性疾病的病理生理学、临床症状和现有治疗方法,并特别强调了AD。这些致命神经退行性疾病的共性为治疗进展提供了支持,并加深了对疾病表现的理解。
专注于生物途径、细胞机制和遗传学共性的研究可能为研究人员提供机会,以确定一些用于疾病预防的新型共同靶点,并开发针对多种神经退行性疾病的有效通用药物。